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Abstract
Background: A low plasma glutamine level at the time of acute admission to the intensive care unit (ICU) is an
independent predictor of an unfavourable outcome in critically ill patients. The primary objective of this study was
to determine whether there are differences in plasma glutamine levels upon non-elective or elective ICU admission.
The secondary objective was to compare glutamine levels over time, and to determine correlations between
glutamine levels and the severity of illness and presence of infection in ICU patients.
Methods: We performed a single-centre observational study in a closed-format, 22-bed, mixed ICU. Plasma glutamine
levels were measured at admission and every morning at 6.00 a.m. during the ICU stay. We aimed to include at least
80 patients per group. The study was approved by the local Medical Ethics Committee.
Results: In 88 patients after elective surgery, the median plasma glutamine level at admission was significantly higher
compared with that in 90 non-elective patients (0.43 mmol/l [0.33–0.55 mmol/l] versus 0.25 mmol/l [0.09–0.37 mmol/l],
P = 0.001). During the ICU stay, plasma glutamine levels remained significantly higher in elective patients than in
non-elective patients. There was a significant correlation between the APACHE IV score and glutamine levels (R = 0.52,
P < 0.001). Moreover, backward linear regression analysis showed that this correlation was independently associated
with the APACHE IV score and the presence of infection, but not with the type of admission.
Conclusions: Plasma glutamine levels are significantly lower after non-elective admission compared with elective
admission to the ICU. A considerable amount of elective and non-elective patients have decreased plasma glutamine
levels, but this is not independently associated with the type of admission. In contrast to previous studies, we found
that plasma glutamine levels were determined by the severity of illness and the presence of an infection.
Trial registration: ClinicalTrials.gov, number NCT02310035.
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Background
Glutamine plays an important role in cell homeostasis
and metabolism because of its role in gluconeogenesis,
nitrogen transport, and synthesis of proteins and nucleic
acids [1, 2]. During critical illness, the use of glutamine
exceeds the supply, and plasma and skeletal muscle pools
of free glutamine are reduced. Rapidly dividing cells, such
as enterocytes and immune-competent cells, are especially
sensitive to glutamine depletion [2].
A low plasma glutamine level at the time of acute
admission to the intensive care unit (ICU) is an inde-
pendent predictor of an unfavourable outcome in critic-
ally ill patients [3, 4]. Previous studies have shown that
30–67 % of patients who were admitted to the ICU had
a glutamine level below 0.42 mmol/l [3–6]. Patients with
lower glutamine levels are older compared with patients
with normal glutamine levels and are more often diag-
nosed as having shock at admission [3].
Major surgery induces a stress response that is charac-
terised by hormonal release and inflammatory processes
[7, 8]. This stress response resembles catabolic stress,
which is found in other forms of critical illness. Whether
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inflammation that is caused by major elective surgery
also leads to a decrease in plasma glutamine levels,
comparable to a decrease during sepsis and other forms
of acute critical illness, is unclear.
The primary objective of the study was to determine
whether there are differences in plasma glutamine levels
upon non-elective or elective ICU admission. Our second-
ary objective was to compare the course of glutamine
levels over time between the two groups during the ICU
stay, and to determine the correlations between glutamine




We performed a single-centre observational study in a
closed-format, 22-bed, mixed ICU in a tertiary teaching
hospital. We included consecutive patients who were
admitted to the ICU from 26 April until 4 July 2014.
Exclusion criteria were age younger than 18 years and
the need for total parenteral nutrition to avoid intraven-
ous glutamine supplementation. Patients were divided
into two groups: those admitted to the ICU after elective
surgery and those with non-elective admission (medical
and acute surgery).
The study was approved by the local Medical Ethics
Committee (Regional Review Committee for Patient-
related Research, Medical Centre Leeuwarden, nWMO
48, 24 March 2014). Informed consent was waived under
the condition that the glutamine measurements were
performed from residue blood samples, taken as part of
standard care. The study was registered in a public regis-
ter (ClinicalTrials.gov, number NCT02310035).
Setting
Blood samples were collected at admission and every
morning at 6.00 a.m. during the ICU stay. According to
protocol, all of the patients were equipped with a nasogas-
tric tube. After non-elective admission, enteral nutrition
was started within 6 h according to our local feeding
protocol. In patients after elective surgery, the feeding
protocol was started as soon as it became clear that pa-
tients would not leave the ICU on day 1. Enteral nutrition
was started at 20 ml/h (Nutrison Protein plus Multi Fiber®;
Nutricia Advanced Medical Nutrition, Danone Baby and
Medical Nutrition B.V.), and every 6 h, the amount of
enteral nutrition was increased to 20 ml/h until the
desired amount was reached. In patients with gastric
residue of more than 250 ml/6 h, the amount of feeding
was not increased. A duodenal feeding tube was placed in
case a patient did not receive 40 ml/h nutrition within
48 h after admission. The desired amount of enteral feed-
ing was 25 kcal/kg/h and 1.2 g protein/kg/h for patients
with a body mass index (BMI) between 18 and 30. In case
of a BMI lower than 18 or greater than 30, a correction
towards ideal body weight was performed [9, 10]. For
patients with a BMI greater than 30, we used the weight
that patients would have had with a BMI of 30 [10].
Enteral glutamine (Glutaperos®; GLNP Life Sciences BV,
27 g daily) was started on day 3 in patients without renal
replacement therapy or liver failure.
Glutamine measurements
Measurement of glutamine was performed with the Bio-
profile 100 plus analyser (Nova Biomedical U.K., Cheshire,
UK). This analyser was originally intended for use for
monitoring metabolites and nutrients in cell culture
systems, and was used in this study for investigational
purposes to monitor glutamine levels in plasma sam-
ples (see Additional file 1).
Statistical analysis
There are no data available on plasma glutamine levels
after elective surgery. Therefore, a true power calculation
was not applicable. Consequently, we estimated a number
of at least 80 patients per group to obtain a difference
between the two groups. Descriptive statistics were used
to summarise the study population. Data are shown as the
mean with standard deviation or median with interquartile
range, depending on the normality of the data. Differences
between groups were measured using the Mann–Whitney
U test. We used the Bonferroni method to account for
multiple comparisons. Backward linear regression ana-
lysis was performed to investigate predictors of glutam-
ine levels at admission.
A two-sided P value < 0.05 was considered significant.
All tests of the data were performed using Statistical
Package for the Social Sciences 21.0 (IBM, New York,
NY, USA).
Results
The patients’ characteristics are shown in Table 1. We
included 88 patients in the elective surgery group (cardiac
surgery [n = 76] and general surgery [n = 12]) and 90 pa-
tients in the non-elective group (sepsis [n = 27], acute
surgery [n = 17], trauma [n = 2], and medical [n = 44]).
Patients in the elective group were significantly older
(P < 0.001) and more often male (P < 0.001) than those
in the non-elective group. The Acute Physiology and
Chronic Health Evaluation (APACHE) IV score was sig-
nificantly higher in the non-elective group than in the
elective group (P < 00.1). Non-elective patients stayed
longer in the ICU, but there was no significant differ-
ence in hospital stay between the groups. One patient
in the elective group died, whereas in the non-elective
group, seven patients did not survive.
The median plasma glutamine level at ICU admission
was significantly higher in elective patients compared
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with non-elective patients (0.43 mmol/l [0.33–0.55 mmol/l]
versus 0.25 mmol/l [0.09–0.37 mmol/l], P = 0.001). During
the ICU stay, plasma glutamine levels remained higher
between elective and non-elective patients, but they tended
to decrease in the elective group as they stayed longer in
the ICU (Table 2).
A total of 112 (65 %) patients had a plasma glutamine
level lower than 0.420 mmol/l at ICU admission. Signifi-
cantly less elective patients showed a plasma glutamine
level lower than 0.420 mmol/l than non-elective patients
(34 vs 74 %, P < 0.001).
We divided the non-elective patients into those with
and without infection. In patients with infection (n = 27),
glutamine levels were significantly lower than those in
patients without infection (Table 3).
There appeared to be a significant correlation between
the APACHE IV score and glutamine levels (R = 0.52,
P < 0.001). Moreover, in backward linear regression ana-
lysis, this correlation was independently associated with
the APACHE IV score and the presence of infection, but
not with the type of admission.
Discussion
In the present study, we found that plasma glutamine
levels were significantly lower in patients with non-elective
admission to the ICU compared with those who were
admitted after elective surgery. Inflammation caused by
elective surgery can lead to a decrease in glutamine levels,
but this is less pronounced compared with other forms of
acute critical illness. Patients who are admitted after elect-
ive surgery are unlikely to have an infection at the time of
admission to the ICU. This could have played a role in the
differences that were found in plasma glutamine levels
between the two groups. Additionally, the time between
the onset of a critical illness and admission to an ICU is
generally longer than the time between the start of surgery
and admission. Therefore, a longer period of catabolic
stress might lead to a further decrease in glutamine levels.
In our study, in the non-elective group, 74 % of patients
had a glutamine level lower than 0.420 mmol/l. The per-
centage of patients with a low glutamine level in our study
is higher than that reported in previous studies [3–5].
Additionally, a considerable amount of patients after elect-
ive surgery had a glutamine level below 0.42 mmol/l. We
did not measure plasma glutamine levels before surgery.
Therefore, whether plasma glutamine levels were already
low before surgery in these patients or whether lowering
plasma glutamine levels was a consequence of surgery is
unknown. Most of the patients in the elective surgery
group underwent cardiac surgery with cardiopulmonary
bypass. Extracorporeal circulation induces an inflamma-
tory response, but there are no clinical data on the effects
on plasma glutamine levels in this situation [11, 12]. In a
small series of patients, a decrease in glutamine levels was
reported after elective abdominal aneurysm surgery [13].
We also measured plasma glutamine levels on days 1
and 2 of the ICU stay. During these days, the difference
in plasma glutamine levels between non-elective and
Table 2 Plasma glutamine levels (mmol/l) at admission, and on
days 1 and 2 after admission
Elective Non-elective P















Values are median [interquartile range] and the number of patients (n)






Age (years) 68 ± 10 59 ± 17 <0.001
Male/female 65 / 33 46 / 44 <0.001
Length (cm) 175 ± 8 174 ± 10 0.25
Weight (kg) 83 ± 13 82 ± 18 0.67
BMI 27 ± 4 27 ± 6 0.71
APACHE IV 46 ± 14 67 ± 29 <0.001
LOS ICU (days) 2 [2–2] 4 [2–7] <0.001
LOS Hospital (days) 6 [4–9] 8 [3–13] 0.71
Survival ICU (%) 100 94 0.01
Survival hospital (%) 99 92 0.02
Laboratory measurements:
CRP mg/l 20 [7–71] 35 [5–171] 0.49
Creatinine μmol/l 87 [71–101] 74 [56–107] 0.08
AF U/l 75 [49–87] 73 [51–107] 0.47
CK U/l 249 [157–474] 90 [47–197] <0.001
Values are mean ± standard deviation or median [interquartile range]
APACHE Acute Physiology and Chronic Health Evaluation, LOS length of stay,
CRP C-reactive protein, AF alkaline phosphatase, CK creatine kinase
Table 3 Plasma glutamine levels (mmol/l) in the non-elective
group, with or without infection
Infection No infection P value















Values are median [interquartile range] and the number of patients (n)
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elective admission remained significant. As expected,
only a few patients stayed longer in the ICU after elect-
ive surgery. In general, these were patients with a more
complex postoperative course, and this could explain the
decline in plasma glutamine levels during their ICU stay.
In non-elective patients with an infection, plasma glu-
tamine levels were significantly lower than those in non-
elective patients without an infection. Additionally, plasma
glutamine levels were independently associated with the
presence of an infection. These findings accentuate the
role of inflammation in plasma glutamine levels.
In contrast to previous studies, we found that glutam-
ine levels were determined by the severity of illness as
expressed by the APACHE IV score [3, 4]. If plasma glu-
tamine levels are solely considered as an additional risk
factor, there is no additional advantage for glutamine
over the well-calibrated APACHE IV model. However,
with regard to organ dysfunction in pro-inflammatory
disease states, our finding adds to the belief that glutam-
ine levels may play a role in the aetiology. In two previ-
ous studies, there appeared to be no relation between
plasma glutamine levels and the APACHE II score or se-
quential organ failure assessment score, but they were
significantly related to mortality [3, 4]. Mortality in the
present study was so low that we did not find an associ-
ation with plasma glutamine levels. Interestingly, in a
study by Rodas et al., the association of plasma glutamine
levels with mortality only became apparent at 6 months
after discharge from the ICU [4].
During the last decades, ICU patients have been treated
with glutamine because available evidence has shown a
benefit in survival when glutamine was provided intraven-
ously to these patients [14]. Recently, the use of glutamine
is under debate because two large randomised controlled
trials in which critically ill patients were treated with
enteral and intravenous glutamine did not show a benefit
in survival [15, 16]. Whether low plasma glutamine levels
during critical illness reflect an adequate response to stress
or reveal a deficiency in the amount of glutamine that can
be used is unclear [17]. Therefore, whether a low plasma
glutamine level is a condition that should be treated is un-
known. Glutamine is involved in many cellular functions,
but its precise role during catabolic stress is not com-
pletely understood.
In all clinical trials that have been published on glutam-
ine supplementation, glutamine was provided without
consideration of plasma glutamine levels in patients who
were studied [14–16]. To determine whether supplemen-
tation of glutamine is beneficial for ICU patients, we
should only treat patients with low plasma glutamine
levels. The method that was used in the present study
enabled us to obtain plasma glutamine measurements
soon after blood sampling. Using this method means that
patients with low plasma glutamine levels early in the
course of critical illness can be identified before consider-
ing supplementation. Future studies need to determine
whether glutamine supplementation is beneficial in pa-
tients with low glutamine levels at ICU admission or
during the ICU stay.
Conclusion
Plasma glutamine levels are significantly lower after non-
elective ICU admission compared with elective ICU admis-
sion. A considerable amount of patients have decreased
plasma glutamine levels, but this is not independently asso-
ciated with the type of admission. In contrast to previous
studies, we found that plasma glutamine levels were
determined by the severity of illness and presence of
an infection.
Key messages
 Plasma glutamine levels are significantly lower after
non-elective ICU admission compared with elective
ICU admission.
 Plasma glutamine levels are not associated with the
type of admission.
 Plasma glutamine levels are determined by the
severity of illness (APACHE IV) and the presence of
an infection.
Additional file
Additional file 1: Glutamine measurements. Measurement of glutamine
was performed with the Bioprofile 100 plus analyser (Nova Biomedical
U.K., Cheshire, UK). This analyser was originally intended for monitoring
metabolites and nutrients in cell culture systems, and was used in this
study to monitor glutamine in plasma samples (plasma separator tubes;
Becton Dickinson B.V., Breda, the Netherlands). For pre-validation of the
analyser, we used water-based controls from the supplier of this analyser,
and the measurements appeared reproducible. Control measurements
were as follows: level 1 mean (± standard deviation) was 1.06 ± 0.061 mmol/l,
the CV (coefficient of variation) was 5.7 %, and n= 143; level 2 mean was
5.31 ± 0.400 mmol/l, the CV was 7.5 %, and n= 152. Using home-made
serum/plasma controls, we obtained the following results: heparin pool 1,
0.558 ± 0.056 mmol/l, CV = 10.1 %, n= 45; serum pool, 1.038 ± 0.086 mmol/l,
CV = 8.3 %, n = 45; and heparin pool 2, 5.279 ± 0.259 mmol/l, CV = 4.9 %,
n = 42. We established that plasma glutamine levels were stable when
plasma was separated from cells within 3 h after sampling and frozen
until analysis (or measured within 3 h after plasma preparation) (Figure S1).
No significant differences in plasma glutamine levels were observed in
outpatients (mean difference [direct measurement versus measurement
after 24 h at −20 °C]: −0.013 mmol/L; 95 % confidence interval: −0.035 –
−0.010; two-sided P = 0.2675, n = 20) and in patients with sepsis (mean
difference [direct measurement versus measurement after 24 h at −20 °C]:
−0.022 mmol/L; 95 % confidence interval: −0.039 – −0.005; two-sided
P = 0.0137, n = 20). In outpatients (n = 51), we obtained a plasma glutamine
reference interval, which ranged from 0.22–0.59 mmol/l (Figure S2).
(PDF 303kkb)
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